Clinical Trial Update: Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity [Phase 3]

View source ↗

Summary

Phase 3 monotherapy trial of brexpiprazole (OPC-34712) in adults with schizophrenia and impulsivity completed with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia with Impulsivity

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia With Impulsivity | Phase 3 | Status: COMPLETED | Results posted: 2018-09-11